logo
#

Latest news with #Doximity

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025
Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

Business Wire

time7 days ago

  • Business
  • Business Wire

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2025 after market close on August 7, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025
Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

Globe and Mail

time7 days ago

  • Business
  • Globe and Mail

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2025 after market close on August 7, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025
Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

Yahoo

time7 days ago

  • Business
  • Yahoo

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

SAN FRANCISCO, July 17, 2025--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2025 after market close on August 7, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. View source version on Contacts For investors: Perry Goldir@ For media: Amanda Coxpr@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Doximity (DOCS) Rises Higher Than Market: Key Facts
Doximity (DOCS) Rises Higher Than Market: Key Facts

Yahoo

time15-07-2025

  • Business
  • Yahoo

Doximity (DOCS) Rises Higher Than Market: Key Facts

In the latest trading session, Doximity (DOCS) closed at $61.55, marking a +2.24% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.14%. On the other hand, the Dow registered a gain of 0.2%, and the technology-centric Nasdaq increased by 0.27%. Prior to today's trading, shares of the medical social networking site had gained 7.65% outpaced the Medical sector's loss of 1.34% and the S&P 500's gain of 3.97%. The investment community will be closely monitoring the performance of Doximity in its forthcoming earnings report. It is anticipated that the company will report an EPS of $0.31, marking a 10.71% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $139.67 million, indicating a 10.26% upward movement from the same quarter last year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $1.46 per share and a revenue of $625.72 million, signifying shifts of +2.82% and +9.7%, respectively, from the last year. It's also important for investors to be aware of any recent modifications to analyst estimates for Doximity. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.55% downward. Doximity presently features a Zacks Rank of #3 (Hold). With respect to valuation, Doximity is currently being traded at a Forward P/E ratio of 41.26. For comparison, its industry has an average Forward P/E of 28.13, which means Doximity is trading at a premium to the group. It's also important to note that DOCS currently trades at a PEG ratio of 4.48. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 2.64. The Medical Info Systems industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 85, finds itself in the top 35% echelons of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Doximity, Inc. (DOCS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Evercore upgrades Doximity, says guidance looks conservative
Evercore upgrades Doximity, says guidance looks conservative

Yahoo

time09-07-2025

  • Business
  • Yahoo

Evercore upgrades Doximity, says guidance looks conservative

-- Evercore ISI upgraded Doximity to Outperform and raised its price target to $70, saying the digital health platform's full-year guidance appears cautious and could be exceeded if recent trends in pharmaceutical spending hold. The firm expects Doximity's core Pharma business to remain steady next year, helped in part by increased spending on GLP-1 drugs, which it estimates could contribute around $60 million in fiscal 2026. That would help offset any potential softness in upselling activity and keep revenue in line with the upper end of company guidance. The company's point-of-care and formulary products, which nearly doubled revenue in fiscal 2025, are expected to continue growing, though at a slower, more sustainable pace. Evercore forecasts that segment alone could reach over $140 million in fiscal 2026. Doximity's total revenue is estimated to reach about $630 million next year, toward the high end of management's range of $619 million to $631 million. If spending patterns remain stable, Evercore sees potential for at least 5% upside to those figures. The brokerage also cited the company's high operating leverage. Because of its lean cost structure, modest outperformance in revenue could lead to meaningful growth in earnings. Evercore estimates adjusted EBITDA could exceed $365 million, compared to the current consensus of around $340 million. Though the stock is not cheap by traditional metrics, Evercore argued that its strong margins and recurring revenue profile justify a premium, especially when compared with peers. It also flagged regulatory risks that could affect pharma ad spending but noted that any shift toward digital or provider-focused advertising could benefit Doximity. Related articles Evercore upgrades Doximity, says guidance looks conservative OpenAI to launch AI-powered web browser to rival Google Chrome William Blair starts Wingstop at Outperform on steady growth, expansion

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store